Literature DB >> 10523323

Endothelial function in hypertension: the role of superoxide anion.

M McIntyre1, D F Bohr, A F Dominiczak.   

Abstract

Much attention has been focused on the role of nitric oxide in hypertension and cardiovascular disease. More recently, the role of superoxide anion and its interaction with nitric oxide has been investigated in this context. This review will concentrate on the role of superoxide in human and experimental hypertension, paying particular attention to the potential sources of superoxide within the vasculature and discussing some of the molecular mechanisms surrounding its production and dismutation. We discuss what is known about the human superoxide dismutase enzymes. We conclude that the balance between nitric oxide and superoxide is more important than the absolute levels of either alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523323     DOI: 10.1161/01.hyp.34.4.539

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  59 in total

Review 1.  Oxidative stress and vascular damage in hypertension.

Authors:  R M Touyz
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Assessment of endothelial function of large, medium, and small vessels: a unified myograph.

Authors:  Xiao Lu; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.

Authors:  Jiaur R Gayen; Kuixing Zhang; Satish P RamachandraRao; Manjula Mahata; Yuqing Chen; Hyung-Suk Kim; Robert K Naviaux; Kumar Sharma; Sushil K Mahata; Daniel T O'Connor
Journal:  Circ Cardiovasc Genet       Date:  2010-08-20

4.  Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis.

Authors:  C Tian; S Fang; X Du; C Jia
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

Review 5.  Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Authors:  Ibra S Fancher; Israel Rubinstein; Irena Levitan
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

6.  NAD(P)H oxidase inhibiting with apocynin improved vascular reactivity in tail-suspended hindlimb unweighting rat.

Authors:  Ran Zhang; Hai-hong Ran; Jin Ma; Yun-gang Bai; Le-jian Lin
Journal:  J Physiol Biochem       Date:  2011-10-21       Impact factor: 4.158

7.  Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat.

Authors:  Shuyang Xie; Ning Xie; Youjie Li; Pingyu Wang; Chao Zhang; Qiang Li; Xiaolin Liu; Jingti Deng; Can Zhang; Changjun Lv
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

8.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 9.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

Review 10.  Free radicals: properties, sources, targets, and their implication in various diseases.

Authors:  Alugoju Phaniendra; Dinesh Babu Jestadi; Latha Periyasamy
Journal:  Indian J Clin Biochem       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.